home / stock / evok / evok news


EVOK News and Press, Evoke Pharma Inc. From 08/10/22

Stock Information

Company Name: Evoke Pharma Inc.
Stock Symbol: EVOK
Market: NASDAQ
Website: evokepharma.com

Menu

EVOK EVOK Quote EVOK Short EVOK News EVOK Articles EVOK Message Board
Get EVOK Alerts

News, Short Squeeze, Breakout and More Instantly...

EVOK - Evoke Pharma Q2 GAAP loss per share narrows, revenue up

Evoke Pharma press release ( NASDAQ: EVOK ): Q2 GAAP EPS of -$0.71 (vs. -$0.85 Y/Y). Revenue of $0.46M (+91.7% Y/Y). For further details see: Evoke Pharma Q2 GAAP loss per share narrows, revenue up

EVOK - Evoke Pharma Reports Second Quarter 2022 Financial Results

SOLANA BEACH, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the second quarter ended June 30, 2022, and recent corp...

EVOK - Evoke Pharma to Report Second Quarter Results on August 10, 2022

SOLANA BEACH, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company is scheduled to release its second quarter on Wednesday, August 10, 2...

EVOK - Evoke Pharma Recognizes Gastroparesis Awareness Month through its Support of The International Foundation for Gastrointestinal Disorders (IFFGD)

Ranked #1 in IFFGD Virtual Walk to spread awareness and support research for gastrointestinal disorders Evoke attending ANMS 2022 meeting August 5-7 in Philadelphia, PA SOLANA BEACH, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specia...

EVOK - Evoke Pharma gets Canadian patent linked to Gimoti nasal spray

Evoke Pharma ( NASDAQ: EVOK ) said the Canadian Intellectual Property Office granted a patent covering methods of use for nasal delivery of Gimoti's formulation, metoclopramide, to treat diabetic gastroparesis (DG). The patent titled “Nasal Formul...

EVOK - Evoke Pharma Expands IP Portfolio with Addition of Canadian Patent Covering GIMOTI Method of Use

SOLANA BEACH, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that the Canadian I...

EVOK - Rhythm Pharmaceuticals, Advent Technologies, Sidus Space among premarket losers' pack

Addex Therapeutics (ADXN) -36% after terminating lead program. ToughBuilt Industries (TBLT) -28%. Advent Technologies (ADN) -13%. Comera Life Sciences (CMRA) -9%. Sidus Space (SIDU) -8%. Aethlon Medical (AEMD) -8%. Rhythm Pharmaceuticals (RYTM) -4% after FDA rejects Rhythm...

EVOK - Why These 3 Penny Stocks Exploded Today 

3 Penny Stocks That Exploded During Trading Today If you’re looking for the best penny stocks to buy, there are hundreds to choose from. And after several days of bearish market trading, we are seeing some penny stocks with explosive gains right now. Although it is hard and n...

EVOK - REV, CPS and GBOX among mid-day movers

Gainers: Sidus Space (SIDU) +94%. Evoke Pharma (EVOK) +50%. Visionary Education Technology Holdings (VEDU) +37%. Heliogen (HLGN) +27%. Ribbon Communications (RBBN) +25%. Digital World Acquisition (DWACW) +22%. Wheels Up Experience (UP) +21%. Austin Gold (AUST) +21%. AeroClean Technologies (AE...

EVOK - Why One Analyst Thinks Robinhood (HOOD) Stock Will Plunge to $5

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Robinhood ( HOOD ) is falling alongside a new analyst rating. This comes from Atlantic Equities analyst John Heagerty. He dropped the stock to “underweight” with a $5 price target. Source: mund...

Previous 10 Next 10